ReGen360 is the integrated academic, research, and development wing of ReGenCare, dedicated to advancing regenerative medicine through a comprehensive 360-degree approach. It serves as a platform where scientific discovery, clinical translation, education, and innovation converge to improve patient care and shape the future of regenerative therapies.
Our vision is to create a centre of excellence that encompasses every dimension of regenerative medicine, from fundamental science and translational research to clinical applications, professional education, skill development, and collaborative innovation. ReGen360 facilitates interdisciplinary partnerships among clinicians, researchers, scientists, engineers, industry, and academic institutions to accelerate the development of safe, evidence-based regenerative solutions.
The activities of ReGen360 include:
– Research: Basic, translational, and clinical research in regenerative medicine, biologics, cell-based therapies, platelet concentrates, tissue engineering, and related technologies.
– Academics: Workshops, masterclasses, continuing medical education (CME) programs, certification courses, fellowships, and knowledge-sharing initiatives for healthcare professionals and students.
– Development: Innovation, product and protocol development, technology translation, quality improvement, multicentre collaborations, and support for clinical implementation.
Guided by the principles of scientific excellence, ethical practice, innovation, and collaboration, ReGen360 aims to build a vibrant ecosystem that nurtures learning, drives research, and transforms regenerative medicine from bench to bedside. By integrating research, education, and development into a unified platform, ReGen360 aspires to deliver a truly 360-degree perspective on regenerative healthcare for clinicians, researchers, and the community.
